Paediatric Medicines

Article type: Research Article

Authors: Donnelly, Fergal

Affiliations: DG RTD, European Commission, Brussels, Belgium. E-mail: Fergal.Donnelly@ec.europa.eu

Abstract: The European Parliament, and the Council Regulation on Medicinal Products for Paediatric Use, intend to increase children's health in Europe by promoting research, development and authorisation of medicines for paediatric use. The main objectives are: to increase the development of medicine for children to ensure that paediatric medicines are subject to high quality research to ensure that medicines for children are appropriately authorised for paediatric use to improve information available on the use fo medicines for children to avoid unnecessary studies in children.

Keywords: FP7, PUMA, Priority List, paediatric

DOI: 10.3233/PPL-2010-0272

Journal: Pharmaceuticals, Policy and Law, vol. 12, no. 1-2, pp. 77-80, 2010